and propagating human-induced pluripotent stem cells. It has been an honor and a privilege for me to serve as editor-in-chief of In Vitro-Animal for the past 5 years, and I thank the SIVB Board of Directors for that privilege. In that time, and especially since the 2007 inception of our association with the Springer publishing house, the number and quality of manuscripts submitted to the journal have increased. A significant proportion of submitted manuscripts and published papers now come from researchers outside the USA so there is an awareness of and a market for In Vitro-Animal beyond the USA or North American research community. I believe that the increased international exposure of In Vitro-Animal bodes well for the future of the journal. Under the leadership of Dr. Okamoto I expect the quality and reputation of the journal to continue to grow, and I hope to see a commensurate increase in the significance of In Vitro-Animal in the many research fields that make use of animal cell and tissue culture technologies.
